Healthcare & Life Sciences
SynsoryBio
United States
About
SynsoryBio develops protein therapeutics engineered to sense their tissue context and activate only in diseased tissue, aiming to improve the therapeutic window of highly potent drugs for diseases including cancer and autoimmune disorders.
Explore SynsoryBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.